SL-28 is a new treatment being tested for people with advanced solid tumors, which are types of cancer that form in organs or tissues. This study is looking to see if SL-28 is safe, how it interacts in the body, and how well it works against tumors. SL-28 is a cell-based therapy, which means it uses cells to help fight cancer. The study is open-label, so both doctors and participants know what treatment is given.
If you decide to join, you'll get SL-28 for 12 weeks, given in a pattern of 5 days on treatment and 2 days off. Doctors will watch closely to find the right dose that works without too many side effects. To be part of the study, you need to be at least 18 years old and have a solid tumor that hasn't responded well to other treatments.
- The study lasts for 12 weeks with regular treatment and check-ups.
- Participants must have a type of cancer that hasn't improved with other therapies.
- Doctors ensure participants are healthy enough to join the study.